Table III.
Females | Males | |||||||
---|---|---|---|---|---|---|---|---|
N=64 | N=52 | |||||||
| ||||||||
Measurements | intercept | β | 95%CI | P† | intercept | β | 95%CI | P† |
Leptin: adiponectin ratio | 0.93 | 0.13 | 0.06–0.19 | <0.01 | 0.55 | 0.17 | 0.10–0.23 | <0.01 |
Body mass index (mg/kg2) | 0.44 | 0.04 | 0.02–0.05 | <0.01 | −0.14 | 0.05 | 0.04–0.07 | <0.01 |
Waist circumference (cm) | 0.08 | 0.02 | 0.008–0.02 | <0.01 | −0.47 | 0.02 | 0.01–0.03 | <0.01 |
Percent body fat (by DXA)* | −0.07 | 0.03 | 0.01–0.05 | <0.01 | 0.27 | 0.03 | 0.02–0.05 | <0.01 |
Visceral adiposity (by CT)** | 1.02 | 1.98 | 1.23–2.73 | <0.01 | 1.15 | 1.46 | 0.82–2.01 | <0.01 |
Lean body mass (kg) | 0.13 | 0.03 | 0.02–0.05 | <0.01 | 0.23 | 0.02 | 0.002–0.03 | 0.02 |
DXA: Dual-energy x-ray absorptiometry scan;
CT: Computed tomography;
P-value adjusting for Cranial radiation therapy, race/ethnicity, age at diagnosis, and interval from cancer diagnosis